| Literature DB >> 35800343 |
Ke Cao1, Ye Liu1, Ningning Liang2, Xia Shen2, Rui Li2, Huiyong Yin2, Leihong Xiang1.
Abstract
Fatty acid (FA) metabolism has been involved in acne vulgaris, a common inflammatory skin disease frequently observed in adolescents and adults, but it remains poorly defined whether the distributions or location of FA in facial sebum and those in the circulation differentially correlate with the disease. In a cohort of 47 moderate acne patients and 40 controls, sebum samples from forehead and chin areas were collected using Sebutape adhesive patches, and erythrocytes were separated from the fasting blood. Total FAs were analyzed by the gas chromatograph-mass spectrometry method. Compared to control female subjects, female patients showed increased levels of saturated fatty acids (SFAs) and monounsaturated fatty acids (MUFAs) from both facial areas, whereas decreased levels of polyunsaturated fatty acids (PUFAs) from chin areas were observed. Interestingly, the levels of docosahexaenoic acid (DHA) in the circulating erythrocytes were significantly decreased in male patients compared with control. In addition, DHA levels in erythrocytes were positively correlated with PUFAs from sebum only in male subjects. Furthermore, female patients with moderate acne had more severe sebum abnormity and chin-specific FA profiles, consistent with higher acne incidences than males in adulthood, especially in the chin areas. Importantly, serum insulin-like growth factor 1 (IGF-1) levels were positively correlated with SFAs and MUFAs from sebum only in male subjects. In summary, differential spatial FA distributions in facial sebum and correlation with those in erythrocytes and IGF1 levels in serum may shed some light on the pathology of acne in male and female adults.Entities:
Keywords: acne (acne vulgaris); erythrocyte (human); fatty acid (composition); insulin-like growth factor 1 (IGF1); sebum
Year: 2022 PMID: 35800343 PMCID: PMC9253609 DOI: 10.3389/fphys.2022.921866
Source DB: PubMed Journal: Front Physiol ISSN: 1664-042X Impact factor: 4.755
Demographic details of control subjects and moderate acne patients.
| Characteristic | Control subjects ( | Moderate acne patients ( |
|---|---|---|
| Male, N, (%) | 18 (45) | 17 (36) |
| Female, N, (%) | 22 (55) | 30 (64) |
| AGE, mean (SD), y | 26.72 (3.154) | 25.67 (3.273)
|
| BMI, mean (SD), kg/m2 | 20.86 (1.578) | 20.94 (1.570)
|
| SER, mean (SD), μg/cm2/minute | ||
| Total | 6.166 (2.931) | 6.577 (2.617)
|
| Male | 6.698 (3.085) | 6.907 (2.971)
|
| Female | 5.711 (2.749) | 6.349 (2.407)
|
| Forehead | 6.221 (2.522) | 6.515 (2.666)
|
| Chin | 6.111 (3.323) | 6.640 (2.597)
|
| IGF1, mean (SD), μg/L | ||
| Total | 167.2 (33.96) | 171.65 (33.19)NS |
| Male | 155.5 (28.49) | 167.14 (34.31)NS |
| Female | 182.29 (34.5) | 174.08 (32.31)NS |
BMI, body mass index; SER, sebum excretion rate; IGF1, insulin-like growth factor 1.
FIGURE 1Percentage of total fatty acids in sebum from control subjects (A) and acne patients (B). GLA, γ-linolenic acid; ALA, α-linolenic acid.
FIGURE 2Heatmaps of quantified fatty acids levels normalized by Z-score from sebum on forehead and chin between males (M) and females (F) in control and acne groups. *p < 0.05, **p < 0.01, and ***p < 0.001 vs. the gender- and site-matched control group; # p < 0.05, ## p < 0.01, and ### p < 0.001 vs. site-matched male control group; $ p < 0.05 and $$ p < 0.01 vs. gender- and group-matched subjects.
Fatty acid profile of erythrocytes between control and acne groups.
| FA of erythrocyte (μg/μl, mean ± SD) | ||||
|---|---|---|---|---|
| Control subjects ( | Moderate acne patients ( | |||
| Male | Female | Male | Female | |
| C12:0 | 0.03 ± 0.01 | 0.05 ± 0.03 | 0.05 ± 0.03 | 0.12 ± 0.07 |
| C14:0 | 0.47 ± 0.12 | 0.51 ± 0.17 | 0.50 ± 0.23 | 0.78 ± 0.37 |
| C15:0 | 0.24 ± 0.06 | 0.25 ± 0.08 | 0.21 ± 0.04 | 0.37 ± 0.20 |
| C16:0 | 48.61 ± 6.58 | 46.68 ± 6.86 | 46.17 ± 6.04 | 50.50 ± 6.12 |
| C17:0 | 0.47 ± 0.05 | 0.49 ± 0.07 | 0.38 ± 0.10 | 0.51 ± 0.07 |
| C18:0 | 14.63 ± 1.32 | 14.35 ± 2.58 | 14.48 ± 2.85 | 16.33 ± 3.67 |
| C16:1 | 0.36 ± 0.18 | 0.37 ± 0.12 | 0.34 ± 0.29 | 0.53 ± 0.35 |
| C18:1 | 33.00 ± 4.74 | 29.41 ± 5.72 | 32.28 ± 5.34 | 32.55 ± 4.35 |
| C18:2 | 26.44 ± 4.03 | 24.91 ± 6.34 | 26.17 ± 2.71 | 28.22 ± 5.91 |
| C18:3 (ALA) | 0.27 ± 0.07 | 0.22 ± 0.09 | 0.27 ± 0.07 | 0.33 ± 0.15 |
| C20:4 | 9.80 ± 1.27 | 10.10 ± 1.82 | 9.45 ± 1.63 | 10.14 ± 2.18 |
| C20:5 | 0.57 ± 0.15 | 0.52 ± 0.15 | 0.54 ± 0.17 | 0.77 ± 0.27 |
| C22:6 | 5.48 ± 0.55 | 6.25 ± 1.17 | 4.58 ± 0.51* | 7.01 ± 1.26# |
ALA, α-linolenic acid; *p < 0.05 vs. the gender-matched control subjects, # p < 0.05 vs. the group-matched male subjects.
FIGURE 3Correlations between Omega-3 PUFA of erythrocytes and FA of sebum from the forehead (A) and chin (B) in male subjects. *p < 0.05 and **p < 0.01.
FIGURE 4Correlations between IGF1 levels and FA of sebum from forehead (A) and chin (B) in male subjects. *p < 0.05 and **p < 0.01.
Categorical analysis of milk consumption and acne.
| Characteristic | Control subjects ( | Moderate acne patients ( | Odds ratio (95% CI) |
|
|---|---|---|---|---|
| Any kind of milk, n (%) | ||||
| Total | ||||
| <250 ml/day | 31 (77.5) | 29 (61.7) | 2.138 (0.793–5.237) | 0.163 |
| ≥250 ml/day | 9 (22.5) | 18 (38.3) | ||
| Male | ||||
| <250 ml/day | 15 (83.3) | 9 (52.9) | 4.444 (0.959–17.86) | 0.075 |
| ≥250 ml/day | 3 (16.7) | 8 (47.1) | ||
| Female | ||||
| <250 ml/day | 16 (72.7) | 20 (66.7) | 1.333 (0.417–4.429) | 0.765 |
| ≥250 ml/day | 6 (27.3) | 10 (33.3) | ||